BYOOVIZ FDA approval date

The FDA approved BYOOVIZ on 17 Sep 2021.

FDA approval date
17 Sep 2021

Drug identity has not yet been verified against registry records

Also recorded as RANIBIZUMAB-NUNA

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2021-09-17DayBYOOVIZFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761202", "applicant_as_listed_by_fda": "SAMSUNG BIOEPIS CO LTD", "brand_names": ["BYOOVIZ"], "active_ingredients": ["RANIBIZUMAB-NUNA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20210917", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026